James Chow
Orthopaedic Surgery · Phoenix, AZNPI 1184765257
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $5,137,260 of the $6,084,239 with a category attached, or 84.4%. Microport Orthopedics Inc accounts for 68.3% of it on its own, with 14 other manufacturers making up the rest. Among orthopaedic surgery clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 748 payments — averaging $8134.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Microport Orthopedics Inc$4.2M
- Smith+Nephew$1.9M
- Orthosensor Inc.$4K
- Stryker$2K
- Davol Inc.$493
- Maxx Orthopedics, Inc.$333
- plus $826 from 9 others
Across 50 payments — averaging $2637.66 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Smith+Nephew$132K
What the payments were for
- Royalty or licence$5,137,26084%
- Consulting fees$444,1387%
- Speaking & faculty fees$407,3907%
- Travel & lodging$74,7231%
- Food & beverage$20,7280%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Microport Orthopedics Inc | 137 | $4,152,836 |
| Smith+Nephew | 573 | $1,924,656 |
| Orthosensor Inc. | 6 | $3,595 |
| Stryker | 9 | $1,500 |
| Davol Inc. | 7 | $493 |
| Maxx Orthopedics, Inc. | 4 | $333 |
| Zimmer Biomet | 3 | $284 |
| Next Science LLC | 1 | $140 |
| Biocomposites Inc | 1 | $130 |
| Johnson & Johnson | 1 | $107 |
| Theragen, Inc. | 2 | $66 |
| Onkos Surgical, Inc. | 1 | $49 |
| Convatec Inc. | 1 | $20 |
| Vericel Corporation | 1 | $16 |
| Amgen | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MPO Hip System$4,020,506
- Journey II$943,640
- REAL INTELLIGENCE$775,952
- NAVIO$667,548
- JOURNEY$353,758
- Legion$234,379
- Navio Surgical System$187,043
- Legion Revision$169,050
- MPO Medial Pivot Knee$131,052
- Journey II XR$113,859
- Journey II BCS$112,872
- Journey Uni$64,075
- Journey II CR$63,537
- K-15 PORK$50,225
- VISIONAIRE Cutting Guides$28,195
- JOURNEY II UK$25,890
- RI.HIP NAVIGATION$24,759
- Tandem$21,767
- Engage Partial Knee System$19,187
- CORI$15,406
How this compares
$6,084,239 in reported general payments places this provider in the 95th percentile of 377 orthopaedic surgery providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amoxicillin | 75 | $106 |
| Ciprofloxacin Hcl | 14 | $20 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Phoenix
- Evan LedermanPhoenix$12M
- Michael McKeePhoenix$3.4M
- Henry ClarkePhoenix$1.9M
- Samuel HarmsenPhoenix$735K
- Anthony HedleyPhoenix$415K
- Matthew SeidelPhoenix$397K
- David OttPhoenix$380K
- Michael WilminkPhoenix$347K
- Judd CummingsPhoenix$269K
- Thomas CarterPhoenix$265K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.